Good Cancer News - If regulatory approval is given to Bristol-Myers this would mean a breakthrough for cancer treatment. Researchers have delivered promising late-stage data on the melanoma drug.
According to research, the good cancer news is that drug has been found to extend overall survival time among previously untreated patients with advanced melanoma. Patients gained an extra four months survival time from the therapy.
The drug, Ipilimumab is designed to whip up an immune system attack on cancer cells, a new approach to stopping cancer with potential to fight an array of tumor types.
An approval by FDA could mean good news to cancer patients all over. We thank God for this good news and believe God will continue to pour wisdom and guidance to all researchers in Jesus Mighty name, Amen.